30 results
PRE 14A
GLTO
Galecto Inc
16 Apr 24
Preliminary proxy
4:00pm
:
reviewing and advising the Board of Directors and management regarding the long-term strategic goals and objectives and the quality and direction … and long-term corporate strategy are more likely to be forwarded than communications relating to ordinary business affairs, personal grievances
8-K
GLTO
Galecto Inc
15 Aug 23
Galecto Announces Topline Results from Phase 2b GALACTIC-1 Trial of GB0139 for the Treatment of Idiopathic Pulmonary Fibrosis
8:00am
, Galecto’s next step in the development of GB1211 is to initiate a long-term, randomized, placebo-controlled, Phase 2a trial in patients with decompensated
8-K
EX-99.1
i0h6ye wqjjsw
15 Aug 23
Galecto Announces Topline Results from Phase 2b GALACTIC-1 Trial of GB0139 for the Treatment of Idiopathic Pulmonary Fibrosis
8:00am
8-K
EX-10.1
vbirl zfwu3wj
9 Feb 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.1
u3mwx9cmmch7fkwz2j5w
27 Jan 22
Results Support Favorable Safety and Tolerability Profile and Target Engagement of GB0139 and Potential for GB0139 in Severe Lung Disease
8:31am
8-K
EX-99.1
djwx50mi7zblkt5l
5 Jan 22
Regulation FD Disclosure
4:02pm
S-3
EX-1.2
rtz 5v1jceq2
4 Nov 21
Shelf registration
4:59pm
DEF 14A
b4xzhn2e7m4li415u6l
14 Apr 21
Definitive proxy
7:00am
10-K
li90 gdy20tnu6j
29 Mar 21
Annual report
6:03am